Order Article Reprints

Escudero-Sánchez R, Ruiz-Ruigómez M, Fernández-Fradejas J, García Fernández S, Olmedo Samperio M, Cano Yuste A, Valencia Alijo A, Díaz-Pollán B, Rodríguez Hernández MJ, Merino De Lucas E, et al. Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection. Journal of Clinical Medicine. 2021; 10(1):2. https://doi.org/10.3390/jcm10010002

Escudero-Sánchez, Rosa, María Ruiz-Ruigómez, Jorge Fernández-Fradejas, Sergio García Fernández, María Olmedo Samperio, Angela Cano Yuste, Angela Valencia Alijo, Beatriz Díaz-Pollán, María Jesús Rodríguez Hernández, Esperanza Merino De Lucas, and et al. 2021. "Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection" Journal of Clinical Medicine 10, no. 1: 2. https://doi.org/10.3390/jcm10010002

Escudero-Sánchez, R., Ruiz-Ruigómez, M., Fernández-Fradejas, J., García Fernández, S., Olmedo Samperio, M., Cano Yuste, A., Valencia Alijo, A., Díaz-Pollán, B., Rodríguez Hernández, M. J., Merino De Lucas, E., Martín Segarra, O., Sáez Bejar, C., Armiñanzas Castillo, C., Gutiérrez-Gutiérrez, B., Rodríguez-Pardo, D., Ramos-Martínez, A., Torre-Cisneros, J., López-Medrano, F., & Cobo Reinoso, J. (2021). Real-World Experience with Bezlotoxumab for Prevention of Recurrence of Clostridioides difficile Infection. Journal of Clinical Medicine, 10(1), 2. https://doi.org/10.3390/jcm10010002